Immune and allergenic effects of the microalga Coccomyxa sp. strain KJ in healthy humans: A pilot study

Background.The Coccomyxa sp.strain KJ (Coccomyxa KJ), a microalga found in Japan, has a potential function in controlling viral infections.Recently, its dry powder has been marketed as a health food product.Objectives.This pilot study investigated the effects of Coccomyxa KJ powder tablet intake on allergic reactions and immune functions in healthy participants. Materials and methods.Nine healthy volunteers (4 males and 5 females) who expressed interest in foods containing Coccomyxa KJ, and were willing to undergo blood tests, were recruited.Each individual was asked to take 2 Coccomyxa KJ powder tablets (0.3 g) before breakfast once a day for 4 weeks.The salivary immunoglobulin A (IgA) level and blood parameters (white blood cell (WBC) count, eosinophil and lymphocyte counts and percentages, natural killer (NK) cell activity, interleukin (IL)-6 level, and T helper (Th)1/Th2 cell ratio) were evaluated at baseline and weeks 2 and 4.Results.The 4-week intake of Coccomyxa KJ did not affect salivary IgA levels, WBC count, eosinophil and lymphocyte counts and percentages, or the Th1/Th2 ratio.There were significant differences in the NK cell activity after 4 weeks, with an average increase of 11.78 (95% confidence interval (95% CI): 6.80-16.76).None of the patients experienced adverse reactions during or after the study. Conclusions.Long-term Coccomyxa KJ intake improved NK cell activity without causing adverse effects on the indicators of local immunity, systemic inflammation and immune response balance.This study suggests that Coccomyxa KJ powder tablets can induce beneficial immune modifications without causing any adverse effects.